Hot Stocks: ABIOMED, Inc. (NASDAQ:ABMD), INSYS Therapeutics, Inc. (NASDAQ:INSY), Rand Capital Corporation (NASDAQ:RAND), The L.S. Starrett Company (NYSE:SCX), Genpact Limited (NYSE:G)

Abiomed, Inc. (NASDAQ:ABMD), reported first quarter fiscal 2016 revenue of $73.4 million, an increase of 50% compared to revenue of $48.8 million for the same period of fiscal 2015. First quarter fiscal 2016 GAAP net income was $8.9 million or $0.20 per diluted share, compared to GAAP net loss of $1.7 million or a loss of $0.04 per diluted share for the prior year period. ABIOMED, Inc. (NASDAQ:ABMD) belongs to Healthcare sector. Its net profit margin is 49.40% and weekly performance is 19.81%. On last trading day company shares ended up $88.80. ABIOMED, Inc. (NASDAQ:ABMD) distance from 50-day simple moving average (SMA50) is 32.22%.

Insys Therapeutics, Inc. (NASDAQ: INSY) announced that the Company will release its financial results for the second quarter 2015 on Thursday, August 6, 2015, before the U.S. financial markets open. INSYS Therapeutics, Inc. (NASDAQ:INSY) shares moved up 0.61% in last trading session and ended the day at $44.77. INSY Gross Margin is 90.40% and its return on assets is 19.10%. INSYS Therapeutics, Inc. (NASDAQ:INSY) quarterly performance is 67.36%.

Rand Capital Corporation (NASDAQ:RAND) reported Achieved $5.16 net asset value (NAV) per share at June 30, 2015, up $0.73 per share, or 16%, over June 30, 2014 Provided $1.6 million as follow-on investments in seven portfolio companies, with the largest additional investments made in SocialFlow, Rheonix, and SciAps Made initial investment of $500,000 in GENICON, a medical device manufacturer and distributor focused exclusively on laparoscopic surgery. On 04 August, Rand Capital Corporation (NASDAQ:RAND) shares decreased -1.45% and was closed at $4.09. RAND EPS growth in last 5 year was 51.30%.

The L.S. Starrett Company (NYSE:SCX) ended the last trading day at $15.99. Company weekly volatility is calculated as 6.78% and price to cash ratio as 5.31. The L.S. Starrett Company (NYSE:SCX) showed a weekly performance of -2.68%.

Genpact Limited (NYSE:G) reported second quarter net income attributable to shareholders of $62.7 million compared to $49.0 million, a year ago. Earnings per share were $0.28, compared to $0.22. Adjusted earnings per share were $0.32, for the quarter. On average, 12 analysts polled by Thomson Reuters expected the company to report profit per share of $0.28 for the quarter. Analysts’ estimates typically exclude special items. Genpact Limited (NYSE:G) shares decreased -0.09% in last trading session and ended the day at $22.25. G Gross Margin is 39.60% and its return on assets is 6.80%. Genpact Limited (NYSE:G) quarterly performance is 0.23%.

Leave a Reply

Your email address will not be published. Required fields are marked *